Here is some info on zolgensma, the drug that is apparently putting a dent in spinraza sales. Another gene therapy now most expensive ever. Interesting though that they claim it is a once off application that effectively fixes the issue permanently.
Novartis set the price at $2.125 million but offers insurers the ability to pay $425,000 a year for five years. This price tag makes Zolgensma the most expensive drug ever approved.
The drug is delivered as a single one-time dose to address the genetic root cause of the disorder, the company says, producing long-term effects.
PYC Price at posting:
6.1¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)